358 related articles for article (PubMed ID: 35447143)
1. Immune regulation in polycystic ovary syndrome.
Luan YY; Zhang L; Peng YQ; Li YY; Liu RX; Yin CH
Clin Chim Acta; 2022 Jun; 531():265-272. PubMed ID: 35447143
[TBL] [Abstract][Full Text] [Related]
2. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
[TBL] [Abstract][Full Text] [Related]
3. Polycystic Ovary Syndrome.
Azziz R
Obstet Gynecol; 2018 Aug; 132(2):321-336. PubMed ID: 29995717
[TBL] [Abstract][Full Text] [Related]
4. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of immune response in PCOS organ system.
Wang J; Yin T; Liu S
Front Immunol; 2023; 14():1169232. PubMed ID: 37215125
[TBL] [Abstract][Full Text] [Related]
6. Polycystic ovary syndrome.
Goudas VT; Dumesic DA
Endocrinol Metab Clin North Am; 1997 Dec; 26(4):893-912. PubMed ID: 9429864
[TBL] [Abstract][Full Text] [Related]
7. Thiazolidinediones for the therapeutic management of polycystic ovary syndrome : impact on metabolic and reproductive abnormalities.
Elkind-Hirsch KE
Treat Endocrinol; 2006; 5(3):171-87. PubMed ID: 16677059
[TBL] [Abstract][Full Text] [Related]
8. New approach to polycystic ovary syndrome and other forms of anovulatory infertility.
Laven JS; Imani B; Eijkemans MJ; Fauser BC
Obstet Gynecol Surv; 2002 Nov; 57(11):755-67. PubMed ID: 12447098
[TBL] [Abstract][Full Text] [Related]
9. Polycystic ovary syndrome in adolescent girls.
Baldauff NH; Witchel SF
Curr Opin Endocrinol Diabetes Obes; 2017 Feb; 24(1):56-66. PubMed ID: 27906711
[TBL] [Abstract][Full Text] [Related]
10. Investigation of common risk factors between polycystic ovary syndrome and Alzheimer's disease: a narrative review.
Sarahian N; Sarvazad H; Sajadi E; Rahnejat N; Eskandari Roozbahani N
Reprod Health; 2021 Jul; 18(1):156. PubMed ID: 34311759
[TBL] [Abstract][Full Text] [Related]
11. Effects of intestinal flora on polycystic ovary syndrome.
Liu J; Liu Y; Li X
Front Endocrinol (Lausanne); 2023; 14():1151723. PubMed ID: 36967808
[TBL] [Abstract][Full Text] [Related]
12. Opportunities and challenges: interleukin-22 comprehensively regulates polycystic ovary syndrome from metabolic and immune aspects.
Geng Y; Liu Z; Hu R; Ma W; Wu X; Dong H; Song K; Xu X; Huang Y; Li F; Song Y; Zhang M
J Ovarian Res; 2023 Jul; 16(1):149. PubMed ID: 37525285
[TBL] [Abstract][Full Text] [Related]
13. A review of nitric oxide and oxidative stress in typical ovulatory women and in the pathogenesis of ovulatory dysfunction in PCOS.
Awonuga AO; Camp OG; Abu-Soud HM
Reprod Biol Endocrinol; 2023 Nov; 21(1):111. PubMed ID: 37996893
[TBL] [Abstract][Full Text] [Related]
14. The peroxisome proliferator activated receptor gamma Pro12Ala polymorphism is associated with a lower hirsutism score and increased insulin sensitivity in women with polycystic ovary syndrome.
Hahn S; Fingerhut A; Khomtsiv U; Khomtsiv L; Tan S; Quadbeck B; Herrmann BL; Knebel B; Müller-Wieland D; Mann K; Janssen OE
Clin Endocrinol (Oxf); 2005 May; 62(5):573-9. PubMed ID: 15853827
[TBL] [Abstract][Full Text] [Related]
15. Women With Polycystic Ovary Syndrome: A Review of Susceptibility to Type 2 Diabetes.
Layacha SY; Biswas DA
Cureus; 2023 Jan; 15(1):e33390. PubMed ID: 36751233
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China.
Feng JG; Guo Y; Ma LA; Xing J; Sun RF; Zhu W
J Cosmet Dermatol; 2018 Jun; 17(3):511-517. PubMed ID: 28940857
[TBL] [Abstract][Full Text] [Related]
17. Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies.
Sanchez-Garrido MA; Tena-Sempere M
Mol Metab; 2020 May; 35():100937. PubMed ID: 32244180
[TBL] [Abstract][Full Text] [Related]
18. The immune system's role in PCOS.
Shamsi M; Ghazavi A; Saeedifar AM; Mosayebi G; Pour SK; Ganji A
Mol Biol Rep; 2022 Nov; 49(11):10689-10702. PubMed ID: 35752698
[TBL] [Abstract][Full Text] [Related]
19. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.
Diamanti-Kandarakis E; Kouli CR; Bergiele AT; Filandra FA; Tsianateli TC; Spina GG; Zapanti ED; Bartzis MI
J Clin Endocrinol Metab; 1999 Nov; 84(11):4006-11. PubMed ID: 10566641
[TBL] [Abstract][Full Text] [Related]
20. Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update.
Abraham Gnanadass S; Divakar Prabhu Y; Valsala Gopalakrishnan A
Arch Gynecol Obstet; 2021 Mar; 303(3):631-643. PubMed ID: 33439300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
